2026-09-15 · South China Morning Post
🔮 “Because the patient could not tolerate further tissue sampling and there was insufficient remaining tissue, the team decided to perform a liquid biopsy for comprehensive genomic profiling and prioritized the test to avoid further delay.”
The expedited blood-based CGP returned in about ten days and revealed a BRAF mutation, a hint from the molecular tumor board – comprising oncologists, pathologists, biologist, data scientists, pharmacists, and surgeons to start a dual targeted therapy. assertive
The Aporia